Oldest pages

Showing below up to 100 results in range #51 to #150.

51. TCRγδ‏‎ (21:28, 14 May 2023)
52. HLA-DR‏‎ (18:36, 16 May 2023)
53. CD11b‏‎ (17:31, 27 May 2023)
54. CD15‏‎ (09:57, 30 May 2023)
55. CD16‏‎ (14:29, 31 May 2023)
56. IgM‏‎ (12:57, 1 June 2023)
57. CD24‏‎ (18:32, 7 June 2023)
58. CD56‏‎ (13:20, 8 June 2023)
59. CD57‏‎ (16:15, 11 June 2023)
60. CD61‏‎ (23:01, 11 June 2023)
61. Extra‏‎ (20:53, 13 June 2023)
62. CD3‏‎ (11:22, 14 June 2023)
63. CD65‏‎ (15:26, 14 June 2023)
64. CD235‏‎ (15:29, 14 June 2023)
65. Key to marker expression table‏‎ (21:00, 17 June 2023)
66. CD2‏‎ (22:36, 17 June 2023)
67. Monoclonal B lymphocytosis‏‎ (22:26, 18 June 2023)
68. Test open‏‎ (11:43, 19 June 2023)
69. Flow cytometric marker pattern of mantle cell lymphoma‏‎ (12:53, 20 June 2023)
70. Flow cytometric marker pattern of chronic lymphocytic leukaemia‏‎ (23:44, 20 June 2023)
71. NEW‏‎ (12:33, 21 June 2023)
72. Detailed description of individual markers used in diagnosis‏‎ (14:37, 28 June 2023)
73. Immunoglobulin light chains‏‎ (21:31, 4 July 2023)
74. FMC7‏‎ (21:33, 4 July 2023)
75. TDT‏‎ (21:34, 4 July 2023)
76. MPO‏‎ (21:34, 4 July 2023)
77. CD5‏‎ (21:36, 4 July 2023)
78. CD10‏‎ (21:36, 4 July 2023)
79. CD13‏‎ (21:37, 4 July 2023)
80. CD14‏‎ (21:38, 4 July 2023)
81. CD19‏‎ (21:38, 4 July 2023)
82. CD22‏‎ (21:39, 4 July 2023)
83. CD23‏‎ (21:40, 4 July 2023)
84. CD25‏‎ (21:42, 4 July 2023)
85. CD34‏‎ (21:43, 4 July 2023)
86. CD38‏‎ (21:43, 4 July 2023)
87. CD79a‏‎ (21:44, 4 July 2023)
88. CD79b‏‎ (21:45, 4 July 2023)
89. CD103‏‎ (21:45, 4 July 2023)
90. CD117‏‎ (21:46, 4 July 2023)
91. CD138‏‎ (21:47, 4 July 2023)
92. CD200‏‎ (21:47, 4 July 2023)
93. Alt‏‎ (11:33, 6 July 2023)
94. CD20‏‎ (13:58, 6 July 2023)
95. Alt Alt‏‎ (11:26, 10 July 2023)
96. Summary tables comparing neoplastic disorders‏‎ (11:29, 10 July 2023)
97. Description of individual markers‏‎ (10:23, 11 July 2023)
98. Expression strength key‏‎ (16:14, 11 July 2023)
99. Flow cytometry: Mantle cell Lymphoma‏‎ (16:18, 11 July 2023)
100. Description of marker expression of specific disorders‏‎ (14:21, 12 July 2023)
101. CD45‏‎ (16:56, 13 July 2023)
102. Flow cytometry: Chronic Lymphocytic leukaemia‏‎ (17:11, 13 July 2023)
103. Flow cytometry: Mantle Cell Lymphoma‏‎ (17:16, 13 July 2023)
104. Flow cytometry: Follicular Lymphoma‏‎ (17:17, 13 July 2023)
105. Flow cytometry: Marginal Zone Lymphoma‏‎ (17:18, 13 July 2023)
106. Flow cytometry: Hairy Cell Leukaemia‏‎ (17:19, 13 July 2023)
107. Flow cytometry: Diffuse Large B-cell Lymphoma‏‎ (17:22, 13 July 2023)
108. Flow cytomtery: Lymphoplasmacytic lymphoma‏‎ (16:05, 14 July 2023)
109. Flow cytometry: Lymphoplasmacytic Lymphoma‏‎ (16:08, 14 July 2023)
110. CD11c‏‎ (16:29, 14 July 2023)
111. Test‏‎ (18:09, 14 July 2023)
112. Marker expression in B-lymphoproliferative disorders‏‎ (18:10, 14 July 2023)
113. Flow cytometry: Plasma cells‏‎ (18:10, 14 July 2023)
114. Marker Tables: B-lymphoproliferative disorders‏‎ (18:24, 14 July 2023)
115. CD33‏‎ (15:43, 17 July 2023)
116. ALT‏‎ (09:55, 28 July 2023)
117. Image Index of red cell forms‏‎ (11:48, 2 October 2023)
118. Important elements in acute myeloid leukaemia diagnosis‏‎ (18:14, 5 October 2023)
119. Main Page‏‎ (12:39, 6 October 2023)
120. CD64‏‎ (09:43, 12 October 2023)
121. CD-classified flow cytometry markers‏‎ (11:07, 16 October 2023)
122. CD36‏‎ (12:36, 17 October 2023)
123. CD71‏‎ (12:50, 17 October 2023)
124. Non CD-classified flow cytometry markers markers‏‎ (12:51, 20 October 2023)
125. MPAL‏‎ (12:00, 27 November 2023)
126. Acute leukaemia types‏‎ (16:52, 28 November 2023)
127. Table‏‎ (14:13, 11 December 2023)
128. Atypical patterns of primitive marker expression in acute leukaemia‏‎ (18:57, 11 December 2023)
129. Immnophenotypic markers in AML‏‎ (12:23, 21 December 2023)
130. AUL‏‎ (11:27, 22 December 2023)
131. Flow Ctrometry:B-lymphoid lineage assignment‏‎ (14:26, 22 December 2023)
132. Flow Cytometry‏‎ (19:04, 22 December 2023)
133. Flow cytometry:Acute Leukaemia of ambiguous lineage not otherwise sepcified‏‎ (19:11, 22 December 2023)
134. Flow cytometry:ALAL-NOS‏‎ (15:11, 31 December 2023)
135. BPDCN‏‎ (13:59, 2 January 2024)
136. ETP-ALL‏‎ (13:16, 4 January 2024)
137. Tables of diagnostic patterns associated with aberrancy or alternative diagnosis in AML‏‎ (13:28, 5 January 2024)
138. Tables of diagnostic markers supporting assignment of primitive phenotype in AML‏‎ (13:49, 5 January 2024)
139. Myeloid lineage-associated markers‏‎ (19:57, 5 January 2024)
140. Myeloid lineage-defining markers‏‎ (19:58, 5 January 2024)
141. Flow Cytometry:B-lymphoid lineage assignment‏‎ (20:19, 5 January 2024)
142. Flow Cytometry:T-Lymphoid lineage assignment‏‎ (20:22, 5 January 2024)
143. Flow Cytometry:Myeloid lineage assignment‏‎ (19:59, 8 January 2024)
144. Flow Cytometry:Myeloid lineage assignment in MPAL‏‎ (12:43, 9 January 2024)
145. Flow Cytometry:B-lymphoid lineage assignment in MPAL‏‎ (12:47, 9 January 2024)
146. Flow Cytometry:T-Lymphoid lineage assignment in MPAL‏‎ (15:28, 9 January 2024)
147. Tables of diagnostic markers supporting lineage assignment in AML‏‎ (11:48, 11 January 2024)
148. Recognition of APL differentiation‏‎ (00:15, 12 January 2024)
149. Additional immunophenotypic markers useful in lineage assignment or subtyping of AML‏‎ (14:19, 12 January 2024)
150. CD123‏‎ (14:43, 12 January 2024)